OCR Документы SEC - - Годовой отчет, доверенное заявление, проспект эмиссии

Основная статистика

CIK

353230

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to

SEC Filings (Chronological Order)

На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.

February 11, 2016	SC 13G/A	OCR / / Boston Partners - ROBECO INVESTMENT MANAGEMENT INC. Passive Investment SC 13G/A 1 ocra221116.htm ROBECO INVESTMENT MANAGEMENT INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Omnicare Inc (Name of Issuer) Common Stock (Title of Class of Securities) 681904108 (CUSIP Number) December 31, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate
February 10, 2016	SC 13G/A	OCR / / HARRIS ASSOCIATES L P - DISCLOSURE DOCUMENT Passive Investment SC 13G/A 1 secfiling.htm DISCLOSURE DOCUMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4 )* Omnicare (Name of Issuer) Common Stock (Title of Class of Securities) 681904108 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate
January 26, 2016	SC 13G/A	OCR / / IRIDIAN ASSET MANAGEMENT LLC/CT Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* Omnicare, Inc.. (Name of Issuer) Common Stock (Title of Class of Securities) 681904108 (CUSIP Number) December 31, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul
July 24, 2015	10-Q	OCR / 10-Q - Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 1-8269 OMNICARE, INC. (Exact Name of Registrant as Specified in Its C
July 24, 2015	EX-12	Statement of Computation of Ratio of Earnings to Fixed Charges Omnicare, Inc. and Subsidiary Companies (in thousands, except ratio) Three months ended June 30, Six months ended June 30, 2015 2014 2015 2014 Income (loss) before income taxes (1) $ 69,5 EX-12 3 q215ex12.htm EXHIBIT 12 Exhibit 12 Statement of Computation of Ratio of Earnings to Fixed Charges Omnicare, Inc. and Subsidiary Companies (in thousands, except ratio) Three months ended June 30, Six months ended June 30, 2015 2014 2015 2014 Income (loss) before income taxes (1) $ 69,552 $ 100,266 $ 193,883 $ 203,577 Add fixed charges: Interest expense 22,348 22,291 44,982 44,696 Amortizati
July 24, 2015	EX-10.1	OMNICARE, INC. Director Deferred Cash Award EX-10.1 2 ex101.htm EXHIBIT 10.1 Exhibit 10.1 FORM AGREEMENT OMNICARE, INC. Director Deferred Cash Award This AWARD AGREEMENT (this “Agreement”) is effective as of [DATE] (the “Grant Date”), by and between Omnicare, Inc., a Delaware corporation (“Omnicare” or the “Company”), and [NAME] (the “Director”), a member of the Company’s Board of Directors (the “Board”). The deferred cash award granted her
February 25, 2015	EX-99.1	Omnicare Reports Fourth-Quarter and Full-Year 2014 Financial Results; Company Provides Full-Year 2015 Guidance EX-99.1 2 q42014pressreleaseex991.htm EXHIBIT 99.1 Exhibit 99.1 news release Omnicare Reports Fourth-Quarter and Full-Year 2014 Financial Results; Company Provides Full-Year 2015 Guidance CINCINNATI, February 25, 2015 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its fourth quarter and full year ended December 31, 2014. Fourth-Quarter Highlights: • Net sales increase of 6.0% to
February 25, 2015	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a8-kq42014pressrelease.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2015 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation o
February 25, 2015	EX-99.2	Fourth-Quarter & Full Year 2014 Financial Results Supplemental Slides Certain of the statements made today and listed within the following presentation slides are forward-looking statements within the meaning of the Private Securities Litigation Refo EX-99.2 3 ocrq42014ex992.htm EXHIBIT 99.2 Fourth-Quarter & Full Year 2014 Financial Results Supplemental Slides Certain of the statements made today and listed within the following presentation slides are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, all statements regarding t
February 12, 2015	SC 13G/A	OCR / / Boston Partners - ROBECO INVESTMENT MANAGEMENT INC. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Omnicare Inc (Name of Issuer) Common Stock (Title of Class of Securities) 681904108 (CUSIP Number) December 31, 2014 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule i
February 11, 2015	SC 13G/A	OCR / / VANGUARD GROUP INC Passive Investment omnicareinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2 )* Name of issuer: Omnicare Inc Title of Class of Securities: Common Stock CUSIP Number: 681904108 Date of Event Which Requires Filing of this Statement: December 31, 2014 Check the appropriate box to designat
February 11, 2015	SC 13G/A	OCR / / HARRIS ASSOCIATES L P Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Omnicare (Name of Issuer) Common Stock (Title of Class of Securities) 681904108 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is f
January 29, 2015	SC 13G/A	OCR / / IRIDIAN ASSET MANAGEMENT LLC/CT Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Omnicare, Inc.. (Name of Issuer) Common Stock (Title of Class of Securities) 681904108 (CUSIP Number) December 31, 2014 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedul
January 12, 2015	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 12, 2015 Omnicare, Inc.
January 12, 2015	EX-99.1	33rd Annual J.P. Morgan Healthcare Conference January 2015 Forward-Looking Statements Certain of the statements made today and listed within the following presentation slides are forward-looking statements within the meaning of the Private Securities EX-99.1 2 omnicareincjpmorganhccpr.htm EXHIBIT 33rd Annual J.P. Morgan Healthcare Conference January 2015 Forward-Looking Statements Certain of the statements made today and listed within the following presentation slides are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, all s
December 10, 2014	EX-3.1	FIFTH AMENDED AND RESTATED BY-LAWS OF OMNICARE, INC. (a Delaware corporation) ARTICLE I Meetings of Stockholders EX-3.1 2 fifthamendedrestatedbylaws.htm BYLAWS Exhibit 3.1 FIFTH AMENDED AND RESTATED BY-LAWS OF OMNICARE, INC. (a Delaware corporation) ARTICLE I Meetings of Stockholders Section 1.01 Place of Meeting. Meetings of stockholders may be held at any place, within or outside the State of Delaware, as designated by the Board of Directors. Section 1.02 Annual Meeting. (a) General Rule. An annual meeting
December 10, 2014	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2014 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 1-8269 31-1001351 (C
November 24, 2014	EX-99.1	OMNICARE AND MCKESSON EXPAND DISTRIBUTION AGREEMENT Expanded relationship to drive greater pharmaceutical sourcing efficiencies for both companies Exhibit 99.1 OMNICARE AND MCKESSON EXPAND DISTRIBUTION AGREEMENT Expanded relationship to drive greater pharmaceutical sourcing efficiencies for both companies • Leverages the strength of Omnicare as the nation’s largest institutional pharmacy and a leading specialty pharmaceutical services provider and McKesson as a global leader in pharmaceutical sourcing and supply chain management • McKesson t
November 24, 2014	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2014 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 1-8269 31-1001351 (
November 21, 2014	EX-4.2	OMNICARE, INC., Company Each of the Guarantors Named Herein and U.S. BANK NATIONAL ASSOCIATION, Trustee _______________ FIRST SUPPLEMENTAL INDENTURE Dated as of November 21, 2014 to INDENTURE Dated as of November 21, 2014 _______________ 4.75% Senior Exhibit 4.2 OMNICARE, INC., Company Each of the Guarantors Named Herein and U.S. BANK NATIONAL ASSOCIATION, Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of November 21, 2014 to INDENTURE Dated as of November 21, 2014 4.75% Senior Notes Due December 1, 2022 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS Section 1.01.Definitions 2 Section 1.02.Other Definitions 13 ARTICLE II THE NOTES Section 2.01.Ti
November 21, 2014	EX-4.1	OMNICARE, INC. SENIOR DEBT SECURITIES Dated as of November 21, 2014 U.S. Bank National Association CROSS-REFERENCE TABLE* Trust Indenture Act Section Indenture Section 310(a)(1) 7.10 (a)(2) 7.10 (a)(3) N.A. (a)(4) N.A. (a)(5) 7.10 (b) 7.10 (c) N.A. 3 EX-4.1 2 seniorindenture.htm BASE INDENTURE Exhibit 4.1 OMNICARE, INC. SENIOR DEBT SECURITIES - INDENTURE Dated as of November 21, 2014 - U.S. Bank National Association Trustee - CROSS-REFERENCE TABLE* Trust Indenture Act Section Indenture Section 310(a)(1) 7.10 (a)(2) 7.10 (a)(3) N.A. (a)(4) N.A. (a)(5) 7.10 (b) 7.10 (c) N.A. 311(a) 7.11 (b) 7.11 (c) N.A. 312(a) 2.07 (b) 13.03 (c) 13.03 313(a) 7.
November 21, 2014	EX-4.3	OMNICARE, INC., Company Each of the Guarantors Named Herein and U.S. BANK NATIONAL ASSOCIATION, Trustee _______________ SECOND SUPPLEMENTAL INDENTURE Dated as of November 21, 2014 to INDENTURE Dated as of November 21, 2014 _______________ 5.00% Senio Exhibit 4.3 OMNICARE, INC., Company Each of the Guarantors Named Herein and U.S. BANK NATIONAL ASSOCIATION, Trustee SECOND SUPPLEMENTAL INDENTURE Dated as of November 21, 2014 to INDENTURE Dated as of November 21, 2014 5.00% Senior Notes Due December 1, 2024 TABLE OF CONTENTS Page ARTICLE I DEFINITIONS Section 1.01.Definitions 2 Section 1.02.Other Definitions 13 ARTICLE II THE NOTES Section 2.01.T
November 21, 2014	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2014 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 1-8269 31-1001351 (
November 18, 2014	EX-10.1	EX-10.1 EX-10.1 2 creditagmtamendno2.htm EXHIBIT Exhibit 10.1 AMENDMENT NO. 2 TO THE AMENDED AND RESTATED CREDIT AGREEMENT AMENDMENT NO. 2, dated as of November 13, 2014 (this “Amendment”), to the Amended and Restated Credit Agreement dated as of September 28, 2012 (as amended by Amendment No. 1 dated as of November 5, 2014 and as further amended and/or restated, supplemented or otherwise modified from ti
November 18, 2014	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2014 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 1-8269 31-1001351 (
November 10, 2014	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2014 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 1-8269 31-1001351 (
November 10, 2014	EX-99.1	EX-99.1 Ex 99.1 - Credit Suisse Presentation
November 10, 2014	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2014 Omnicare, Inc.
November 7, 2014	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2014 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 1-8269 31-1001351 (C
November 7, 2014	FWP	Omnicare, Inc. Pricing Term Sheet November 6, 2014 Free Writing Prospectus Issuer Free Writing Prospectus filed pursuant to Rule 433 Registration No.
November 7, 2014	EX-1.1	OMNICARE, INC. $400,000,000 4.750% Senior Notes due 2022 $300,000,000 5.000% Senior Notes due 2024 Underwriting Agreement EX-1.1 2 exhibit11.htm EXHIBIT 1.1 Exhibit 1.1 EXECUTION VERSION OMNICARE, INC. $400,000,000 4.750% Senior Notes due 2022 $300,000,000 5.000% Senior Notes due 2024 Underwriting Agreement November 6, 2014 MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED, As Representative of the several Underwriters listed in Schedule 1 hereto c/o MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED One Bryant Park
November 5, 2014	EX-99.2	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM EX-99.2 3 ex992-consentofpricewaterh.htm CONSENT OF PRICEWATERHOUSECOOPERS CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S‑8 (Nos. 333-77845, 333-95949, 333-36874, 333-120450, and 333-196208) of Omnicare, Inc. of our report dated February 19, 2014, except with respect to our opinion on the consolid
November 5, 2014	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2014 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 1-8269 31-1001351 (C
November 5, 2014	EX-99.1	Report of Independent Registered Public Accounting Firm EX-99.1 2 ex991-financialstatementsa.htm FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA Table of Contents Exhibit 99.1 ITEM 8. - FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA Index to Consolidated Financial Statements and Financial Statement Schedule PAGE Financial Statements: Report of Independent Registered Public Accounting Firm 2 Consolidated Statements of Comprehensive Income (Loss) 3 Consolidated
November 5, 2014	424B5	Subject to Completion Preliminary Prospectus Supplement dated November 5, 2014 424B5 Table of Contents The information in this prospectus supplement is not complete and may be changed.
October 31, 2014	EX-4.1	Omnicare, Inc. 3.25% Convertible Senior Exchange Debentures due 2035 Dated as of November 5, 2014 Omnicare Purchasing Company, L.P. as GUARANTOR U.S. Bank National Association as TRUSTEE TABLE OF CONTENTS Exhibit 4.1 Omnicare, Inc. 3.25% Convertible Senior Exchange Debentures due 2035 INDENTURE Dated as of November 5, 2014 Omnicare Purchasing Company, L.P. as GUARANTOR U.S. Bank National Association as TRUSTEE TABLE OF CONTENTS Page ARTICLE I. DEFINITIONS AND INCORPORATION BY REFERENCE 1 Section 1.1 Definitions 1 Section 1.2 Other Definitions 5 Section 1.3 [Reserved] 6 Section 1.4 Rules of Construc
October 31, 2014	EX-10.1	EXCHANGE AGREEMENT EX-10.1 3 exhibit101.htm FORM OF EXCHANGE AGREEMENT Exhibit 10.1 EXCHANGE AGREEMENT (the “Undersigned”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom the Undersigned holds contractual and investment authority (each Account, as well as the Undersigned if it is exchanging Existing Notes (as defined below) hereunder, a “Holder”), enters into this
October 31, 2014	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2014 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 1-8269 31-1001351 (C
October 24, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2014 Omnicare, Inc.
October 24, 2014	EX-99.2	EX-99.2 EX-99.2 3 ocrerex992q32014.htm EXHIBIT
October 24, 2014	EX-99.1	Omnicare Reports Third-Quarter 2014 Financial Results; Company Updates Full-Year 2014 Guidance Exhibit 99.1 news release Omnicare Reports Third-Quarter 2014 Financial Results; Company Updates Full-Year 2014 Guidance CINCINNATI, October 24, 2014 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its third quarter ended September 30, 2014. Third-Quarter Highlights: • Net sales increase of 6.1% to $1.6 billion • Adjusted cash earnings per diluted share from continuing operations
July 23, 2014	EX-99.2	EX-99.2 EX-99.2 3 ex992ocrslidesq22014.htm EXHIBIT
July 23, 2014	EX-99.1	Omnicare Reports Second-Quarter 2014 Financial Results Exhibit 99.1 news release Omnicare Reports Second-Quarter 2014 Financial Results CINCINNATI, July 23, 2014 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its second-quarter ended June 30, 2014. Second-Quarter Highlights: • Net sales increase of 7.1% to $1.6 billion • Adjusted cash earnings per diluted share from continuing operations 7.1% higher to $0.91; GAAP earnings per dilute
July 23, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2014 Omnicare, Inc.
July 2, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2014 Omnicare, Inc.
May 27, 2014	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2014 Omnicare, Inc.
May 22, 2014	S-8	- S-8 As filed with the Securities and Exchange Commission on May 22, 2014 Registration No.
May 22, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2014 Omnicare, Inc.
May 15, 2014	EX-99.1	EX-99.1 EX-99.1 2 ex991-boamlconferenceslides.htm EXHIBIT
May 15, 2014	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2014 Omnicare, Inc.
April 23, 2014	EX-99.2	EX-99.2 EX-99.2 3 ocrerex992q12014.htm EXHIBIT
April 23, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2014 Omnicare, Inc.
April 23, 2014	EX-99.1	Omnicare Reports First-Quarter 2014 Financial Results EX-99.1 2 ocrerex991q12014.htm EXHIBIT Exhibit 99.1 news release Omnicare Reports First-Quarter 2014 Financial Results CINCINNATI, April 23, 2014 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its first-quarter ended March 31, 2014. First-Quarter Highlights: • Net sales increase of 7.7% to $1.6 billion • Adjusted cash earnings per diluted share from continuing operations 8.3% hig
April 18, 2014	DEF 14A	- DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confid
April 16, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): April 14, 2014 Omnicare, Inc.
March 25, 2014	EX-99.1	Omnicare Announces CEO Transition Plan John Workman to Retire by End of 2014 Nitin Sahney Appointed Chief Executive Officer-Elect Company Reaffirms 2014 Guidance Exhibit 99.1 Omnicare Announces CEO Transition Plan John Workman to Retire by End of 2014 Nitin Sahney Appointed Chief Executive Officer-Elect Company Reaffirms 2014 Guidance CINCINNATI, March 25, 2014 - Omnicare, Inc. (NYSE: OCR) today announced that Chief Executive Officer, John Workman, 62, will retire from the Company and its Board on or before December 31, 2014. Nitin Sahney, President and Ch
March 25, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): March 24, 2014 Omnicare, Inc.
February 28, 2014	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2014 Omnicare, Inc.
February 19, 2014	EX-99.1	Omnicare Reports Fourth-Quarter and Full-Year 2013 Financial Results; Company Provides Full-Year 2014 Guidance EX-99.1 2 q42013pressreleaseex991.htm EXHIBIT Exhibit 99.1 news release Omnicare Reports Fourth-Quarter and Full-Year 2013 Financial Results; Company Provides Full-Year 2014 Guidance CINCINNATI, February 19, 2014 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its fourth quarter and full year ended December 31, 2013. Fourth-Quarter Highlights: • Net sales increase of 5.1% to $1.54
February 19, 2014	EX-99.2	EX-99.2 EX-99.2 3 q42013prex992.htm EXHIBIT
February 19, 2014	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2014 Omnicare, Inc.
February 14, 2014	SC 13G/A	OCR / / Brahman Capital Corp. - SCHEDULE 13G AMENDMENT FILING Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.
February 14, 2014	SC 13G/A	OCR / / HARRIS ASSOCIATES L P Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Omnicare (Name of Issuer) Common Stock (Title of Class of Securities) 681904108 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is f
February 12, 2014	CORRESP	- VIA EDGAR February 12, 2014 Mr. Jim B. Rosenberg Senior Assistant Chief Accountant United States Securities and Exchange Commission Division of Corporate Finance Mail Stop 4720 Washington, D.C. 20549 Re: Omnicare, Inc. Form 10-K for Fiscal Year Ended December 31, 2012 Filed February 19, 2013 File No. 001-08269 Dear Mr. Rosenberg: This letter constitutes the response of Omnicare, Inc. (the “Company
February 12, 2014	SC 13G	OCR / / Boston Partners Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Omnicare Inc (Name of Issuer) Common Stock (Title of Class of Securities) 681904108 (CUSIP Number) December 31, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is
February 12, 2014	SC 13G/A	OCR / / VANGUARD GROUP INC Passive Investment SC 13G/A 1 omnicareinc.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1 )* Name of issuer: Omnicare Inc Title of Class of Securities: Common Stock CUSIP Number: 681904108 Date of Event Which Requires Filing of this Statement: December 31, 2013 Check the appropriate box to designate the rule pursuant to which this
February 4, 2014	SC 13G/A	OCR / / IRIDIAN ASSET MANAGEMENT LLC/CT Passive Investment SC 13G/A 1 omnicare13ga3123113.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Omnicare, Inc.. (Name of Issuer) Common Stock (Title of Class of Securities) 681904108 (CUSIP Number) December 31, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the
January 14, 2014	EX-99.1	EX-99.1
January 14, 2014	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 14, 2014 Omnicare, Inc.
January 3, 2014	CORRESP	- 900 Omnicare Center 201 East 4th Street Cincinnati, OH, 45202-4160 TEL 513.719.2600 800.990.6664 FAX 513.719.2620 VIA EDGAR January 3, 2014 Mr. Jim B. Rosenberg Senior Assistant Chief Accountant United States Securities and Exchange Commission Division of Corporate Finance Mail Stop 4720 Washington, D.C. 20549 Re: Omnicare, Inc. Form 10-K for Fiscal Year Ended December 31, 2012 Filed February 19,
December 6, 2013	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2013 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 1-8269 31-1001351 (C
November 13, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 a8kcreditsuisse11-13x13.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): November 13, 2013 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation
November 13, 2013	EX-99.1	EX-99.1 EX-99.1 2 ex991creditsuissehelathcar.htm EXHIBIT
October 23, 2013	EX-99.1	Omnicare Reports Third-Quarter 2013 Financial Results; Company Updates Full-Year 2013 Guidance EX-99.1 2 ocrerex991q32013.htm EXHIBIT Exhibit 99.1 news release Omnicare Reports Third-Quarter 2013 Financial Results; Company Updates Full-Year 2013 Guidance CINCINNATI, October 23, 2013 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its third quarter ended September 30, 2013. Third-Quarter Highlights: • Net sales increase of 5.3% to $1.6 billion • Adjusted cash earnings per di
October 23, 2013	EX-99.2	EX-99.2 EX-99.2 3 exhibit992slides.htm EXHIBIT
October 23, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): October 23, 2013 Omnicare, Inc.
September 6, 2013	8-K	Other Events 8-K 1 a10b5-18k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2013 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organizat
August 23, 2013	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2013 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 1-8269 31-1001351 (Co
August 23, 2013	EX-99.1	Omnicare Announces Exchange and Repurchase Transactions in Connection with Certain of its Senior Subordinated Notes Exhibit 99.1 news release Omnicare Announces Exchange and Repurchase Transactions in Connection with Certain of its Senior Subordinated Notes CINCINNATI, August 22, 2013 - Omnicare, Inc. (NYSE: OCR) (the “Company”) announced today that it has entered into separate, privately negotiated exchange agreements under which it will retire approximately $180.46 million in aggregate principal amount of its
August 23, 2013	EX-4.2	OMNICARE, INC., Each of the Guarantors Named Herein U.S. BANK NATIONAL ASSOCIATION (as successor trustee to SunTrust Bank), NINTH SUPPLEMENTAL INDENTURE Dated as of August 28, 2013 Dated as of June 13, 2003 3.50% Convertible Senior Subordinated Notes Exhibit 4.2 OMNICARE, INC., Issuer Each of the Guarantors Named Herein and U.S. BANK NATIONAL ASSOCIATION (as successor trustee to SunTrust Bank), Trustee NINTH SUPPLEMENTAL INDENTURE Dated as of August 28, 2013 to INDENTURE Dated as of June 13, 2003 3.50% Convertible Senior Subordinated Notes Due 2044 TABLE OF CONTENTS Page Article I Definitions 1.01. Definitions 2 1.02. Other Definitions 10 1.03
August 23, 2013	EX-10.1	EXCHANGE AGREEMENT Exhibit 10.1 EXCHANGE AGREEMENT (the “Undersigned”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom the Undersigned holds contractual and investment authority (each Account, as well as the Undersigned if it is exchanging Existing Notes (as defined below) hereunder, a “Holder”), enters into this Exchange Agreement (the “Agreement”) with Omnicare,
August 15, 2013	EX-99.1	COMMONWEALTH OF KENTUCKY KENTON CIRCUIT COURT FOURTH DIVISION CASE NO. 10-CI-01212 MANVILLE PERSONAL INJURY SETTLEMENT TRUST, derivatively on behalf of OMNICARE, INC., Plaintiff, v. JOEL F. GEMUNDER, JOHN T. CROTTY, SANDRA E. LANEY, ANDREA R. LINDELL COMMONWEALTH OF KENTUCKY KENTON CIRCUIT COURT FOURTH DIVISION CASE NO. 10-CI-01212 MANVILLE PERSONAL INJURY SETTLEMENT TRUST, derivatively on behalf of OMNICARE, INC., Plaintiff, v. JOEL F. GEMUNDER, JOHN T. CROTTY, SANDRA E. LANEY, ANDREA R. LINDELL, JOHN H. TIMONEY, AMY WALLMAN, JAMES D. SHELTON, STEVEN J. HEYER, DAVID W. FROESEL, JR., PATRICK E. KEEFE, CHERYL D. HODGES, and T. E. BIEN, Defendan
August 15, 2013	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2013 Omnicare, Inc.
July 31, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2013 Omnicare, Inc.
July 24, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2013 Omnicare, Inc.
July 24, 2013	EX-99.2	EX-99.2 EX-99.2 3 exhibit9922013q2slides.htm SUPPLEMENTAL SLIDES
July 24, 2013	EX-99.1	Omnicare Reports Second-Quarter 2013 Financial Results; Company Raises Full-Year 2013 Guidance EX-99.1 2 ocrerex991q22013.htm PRESS RELEASE Exhibit 99.1 news release Omnicare Reports Second-Quarter 2013 Financial Results; Company Raises Full-Year 2013 Guidance CINCINNATI, July 24, 2013 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its second quarter ended June 30, 2013. Second-Quarter Highlights: • Gross profit of $378 million; 19 basis-point gross margin rate increase •
July 5, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits 8-K 1 a8-kxcarlsonboardappointme.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2013 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or
July 5, 2013	EX-99.1	Omnicare Appoints James Carlson to Board of Directors news release Omnicare Appoints James Carlson to Board of Directors CINCINNATI, July 5, 2013 - Omnicare, Inc.
June 21, 2013	8-K	Other Events 8-K 1 a8kkindred.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): June 21, 2013 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization)
May 24, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2013 Omnicare, Inc.
May 16, 2013	EX-99.1	EX-99.1 EX-99.1 2 exhibit991boaml2013hcconfe.htm EXHIBIT
May 16, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 a8-kshellboaml2013hcconfer.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2013 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or
April 24, 2013	EX-99.1	Omnicare Reports First-Quarter 2013 Financial Results EX-99.1 2 ocrerex991q12013.htm EXHIBIT Exhibit 99.1 news release Omnicare Reports First-Quarter 2013 Financial Results CINCINNATI, April 24, 2013 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its first quarter ended March 31, 2013. First-Quarter Highlights: • Gross profit of $371 million; 121 basis-point expansion in gross margin rate • Adjusted cash earnings per diluted share 1
April 24, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a8kshellq12013pr.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2013 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organiz
April 24, 2013	EX-99.2	EX-99.2 EX-99.2 3 exhibit9922013q1slides.htm Q1 2013 SLIDES
April 19, 2013	DEF 14A	- DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of
March 12, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2013 Omnicare, Inc.
March 12, 2013	EX-99.1	EX-99.1 EX-99.1 2 exhibit991barclaysglobalhe.htm EXHIBIT
March 5, 2013	EX-99.1	EX-99.1 EX-99.1 2 exhibit991cowenhcconferenc.htm EXHIBIT
March 5, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 a8-kcowenhcconference3x5x13.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2013 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation
February 27, 2013	EX-99.1	John Bernbach Appointed to Omnicare's Board of Directors news release John Bernbach Appointed to Omnicare's Board of Directors CINCINNATI, February 27, 2013 - Omnicare, Inc.
February 27, 2013	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8-K 1 a2-23x138xkbernbachboardap.htm 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported) - February 27, 2013 OMNICARE, INC. (Exact Name of Registrant as Specified in Charter) DELAWARE 1-8269 31-1001351 (State or Other Jurisdiction of Incorporatio
February 25, 2013	EX-99.1	EX-99.1
February 25, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 a8-kshelljpmorganhyconfere.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2013 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporati
February 19, 2013	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2013 Omnicare, Inc.
February 19, 2013	EX-99.1	Omnicare Reports Fourth-Quarter and Full-Year 2012 Financial Results; Company Provides Full-Year 2013 Guidance EX-99.1 2 ocrerex9912-19x13.htm PRESS RELEASE Exhibit 99.1 news release Omnicare Reports Fourth-Quarter and Full-Year 2012 Financial Results; Company Provides Full-Year 2013 Guidance CINCINNATI, February 19, 2013 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its fourth quarter and full year ended December 31, 2012. Fourth-Quarter Highlights: • Gross profit increase of 4.7% to $3
February 19, 2013	EX-99.2	EX-99.2 EX-99.2 3 exhibit9922012prslides.htm SUPPLIMENTAL SLIDES
February 14, 2013	SC 13G/A	OCR / / Brahman Capital Corp. - SCHEDULE 13G HOLDINGS REPORT AMENDMENT Passive Investment SC 13G/A 1 OCR123112a2.htm SCHEDULE 13G HOLDINGS REPORT AMENDMENT SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Omnicare, Inc. (Name of Issuer) Common Stock, $1 par value per share (Title of Class of Securities) 681904108 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Che
February 13, 2013	SC 13G	OCR / / VANGUARD GROUP INC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 0 )* Name of issuer: Omnicare Inc Title of Class of Securities: Common Stock CUSIP Number: 681904108 Date of Event Which Requires Filing of this Statement: December 31, 2012 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: (X) Rul
February 11, 2013	SC 13G/A	OCR / / HARRIS ASSOCIATES L P Passive Investment SC 13G/A 1 ocr13GA123112.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* OMNICARE (Name of Issuer) Common Stock (Title of Class of Securities) 681904108 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuan
January 31, 2013	SC 13G/A	OCR / / IRIDIAN ASSET MANAGEMENT LLC/CT Passive Investment SC 13G/A 1 omnicare13ga2123112.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Omnicare, Inc.. (Name of Issuer) Common Stock (Title of Class of Securities) 681904108 (CUSIP Number) December 31, 2012 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the
January 8, 2013	EX-99.1	EX-99.1
January 8, 2013	8-K	Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2013 Omnicare, Inc.
December 20, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2012 Omnicare, Inc.
December 7, 2012	EX-99.1	EX-99.1 EX-99.1 2 exhibit991slides2012analys.htm SLIDES
December 7, 2012	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): December 7, 2012 Omnicare, Inc.
November 29, 2012	8-K	Entry into a Material Definitive Agreement, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): November 28, 2012 Omnicare, Inc.
October 31, 2012	EX-99.1	Omnicare Reports Third-Quarter 2012 Financial Results; Company Raises Full-Year 2012 Guidance EX-99.1 2 ocrerex991103112.htm EXHIBIT 99.1 Exhibit 99.1 news release Omnicare Reports Third-Quarter 2012 Financial Results; Company Raises Full-Year 2012 Guidance CINCINNATI, October 31, 2012 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its third quarter ended September 30, 2012. Third-Quarter Highlights: • Gross profit increase of 7.3% to $371 million; 232 basis-point expansi
October 31, 2012	EX-99.2	EX-99.2 EX-99.2 3 exhibit992q32012.htm EXHIBIT 99.2
October 31, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2012 Omnicare, Inc.
October 4, 2012	EX-10.1	AMENDMENT NO. 2 EXHIBIT 10.1 AMENDMENT NO. 2 Amendment NO. 2 (this “Amendment”), dated as of September 28, 2012, to that certain Credit Agreement (the “Credit Agreement”, with capitalized terms used herein and not defined herein having the meanings assigned to therein), entered into as of August 24, 2011, as amended on September 12, 2012, among Omnicare, Inc., a Delaware corporation (the “Borrower”), each lender
October 4, 2012	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported) – September 28, 2012 OMNICARE, INC. (Exact Name of Registrant as Specified in Charter) DELAWARE 1-8269 31-1001351 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employe
October 4, 2012	EX-10.2	U.S. $725,000,000 AMENDED AND RESTATED CREDIT AGREEMENT Dated as of August 24. 2011, Amended and Restated as of September 28, 2012 by and among OMNICARE, INC., as the Borrower, THE LENDERS FROM TIME TO TIME PARTY HERETO JPMORGAN CHASE BANK, N.A., as EX-10.2 3 exhibit102arcreditagreemen.htm EXHIBIT 10.2 EXHIBIT 10.2 EXHIBIT A U.S. $725,000,000 AMENDED AND RESTATED CREDIT AGREEMENT Dated as of August 24. 2011, Amended and Restated as of September 28, 2012 by and among OMNICARE, INC., as the Borrower, THE LENDERS FROM TIME TO TIME PARTY HERETO JPMORGAN CHASE BANK, N.A., as Syndication Agent, BARCLAYS BANK PLC, as a Co-Documentation Agent, GOLDMA
September 27, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): September 21, 2012 Omnicare, Inc.
September 18, 2012	EX-99.1	Omnicare Specialty Summit September 18, 2012 EX-99.1 2 totalsummitdeckfinal2.htm SLIDES Omnicare Specialty Summit September 18, 2012 Forward-Looking Statement Certain of the statements made today and listed within the following presentation slides are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward- looking statements include, but are not limited to, all statements regardin
September 18, 2012	8-K	Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 a8-kshell9x18x12.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): September 18, 2012 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Org
September 13, 2012	EX-99.1	Omnicare Appoints John L. Workman Chief Executive Officer Appoints Nitin Sahney, Chief Operating Officer, to the additional role of President and Robert “Rocky” Kraft as Chief Financial Officer EX-99.1 2 pressreleaseofomnicareincd.htm PRESS RELEASE news release Omnicare Appoints John L. Workman Chief Executive Officer Appoints Nitin Sahney, Chief Operating Officer, to the additional role of President and Robert “Rocky” Kraft as Chief Financial Officer CINCINNATI, September 13, 2012 - Omnicare, Inc. (NYSE: OCR) announced today that its Board of Directors has named John L. Workman Chief Ex
September 13, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported) - September 11, 2012 OMNICARE, INC. (Exact Name of Registrant as Specified in Charter) DELAWARE 1-8269 31-1001351 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employe
July 25, 2012	EX-99.1	Omnicare Reports Second-Quarter 2012 Financial Results; Company Raises Full-Year 2012 Guidance Exhibit 99.1 news release Omnicare Reports Second-Quarter 2012 Financial Results; Company Raises Full-Year 2012 Guidance CINCINNATI, July 25, 2012 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its second quarter ended June 30, 2012. Year-Over-Year Highlights: • Gross profit increase of 9.2% to $367.3 million; 230 basis-point expansion in gross margin rate • Adjusted cash earning
July 25, 2012	EX-99.2	EX-99.2 EX-99.2 3 q22012exhibit992slides.htm SLIDES
July 25, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a8kshellq22012pr.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2012 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization
July 9, 2012	8-K	Other Events 8-K 1 a8kshell7-9x12filing.htm SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported) - July 9, 2012 OMNICARE, INC. (Exact Name of Registrant as Specified in Charter) DELAWARE 1-8269 31-1001351 (State or Other Jurisdiction of Incorporation) (Commission
June 12, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported) - June 10, 2012 OMNICARE, INC. (Exact Name of Registrant as Specified in Charter) DELAWARE 1-8269 31-1001351 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Ide
June 12, 2012	EX-99.1	Omnicare Appoints John L. Workman as Interim CEO; BOARD ACCEPTS JOHN FIGUEROA'S RESIGNATION Nitin Sahney Appointed COO Board Initiates Search for Permanent CEO 2012 Guidance Unaffected EX-99.1 2 pressrelease.htm PRESS RELEASE news release Omnicare Appoints John L. Workman as Interim CEO; BOARD ACCEPTS JOHN FIGUEROA'S RESIGNATION Nitin Sahney Appointed COO Board Initiates Search for Permanent CEO 2012 Guidance Unaffected CINCINNATI, June 11, 2012 - Omnicare, Inc. (NYSE: OCR) announced today that its Board of Directors has appointed President and CFO John L. Workman as interim CEO
May 24, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - APPOINTMENT OF SAM R. LENO SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported) - May 24, 2012 OMNICARE, INC. (Exact Name of Registrant as Specified in Charter) DELAWARE 1-8269 31-1001351 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Iden
May 24, 2012	8-K	Submission of Matters to a Vote of Security Holders - RESULTS OF ANNUAL SHAREHOLDERS MEETING SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported) - May 23, 2012 OMNICARE, INC. (Exact Name of Registrant as Specified in Charter) DELAWARE 1-8269 31-1001351 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Iden
May 24, 2012	EX-99.1	Sam R. Leno Appointed to Omnicare's Board of Directors Sam R. Leno Appointed to Omnicare's Board of Directors CINCINNATI, May 24, 2012 - Omnicare, Inc. (NYSE:OCR), today announced the appointment of Sam R. Leno to its Board of Directors and he will also become a member of the Audit Committee. Mr. Leno has more than 40 years of business experience with multinational companies, the vast majority within the healthcare sector. He recently retired as Execu
May 16, 2012	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2012 Omnicare, Inc.
May 16, 2012	EX-99.1	EX-99.1 EX-99.1 2 bankofamericapresentations.htm SLIDE PRESENTATION
May 11, 2012	8-K	Financial Statements and Exhibits, Other Events 8-K 1 a12-1206118k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported) – May 10, 2012 OMNICARE, INC. (Exact Name of Registrant as Specified in Charter) DELAWARE 1-8269 31-1001351 (State or Ot
May 11, 2012	EX-99.1	Omnicare Announces Agreement with DEA Settlement amount fully reserved and previously disclosed Exhibit 99.1 news release Omnicare Announces Agreement with DEA Settlement amount fully reserved and previously disclosed CINCINNATI, May 11, 2012 — Omnicare, Inc. (NYSE:OCR) today announced a civil settlement with the United States Department of Justice relating to a previously-disclosed investigation by the Drug Enforcement Administration (“DEA”) of alleged errors and deficiencies in dispensing
May 1, 2012	8-K	Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2012 Omnicare, Inc.
May 1, 2012	EX-99.1	EX-99.1 EX-99.1 2 goldmansachsslides.htm
April 26, 2012	EX-99.2	EX-99.2 EX-99.2 3 exhibit99242612.htm EXHIBIT 99.2
April 26, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a8-k4x26x12.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2012 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 1-
April 26, 2012	EX-99.1	Omnicare Reports First-Quarter 2012 Financial Results EX-99.1 2 ocrerex99142612.htm EXHIBIT 99.1 Exhibit 99.1 news release Omnicare Reports First-Quarter 2012 Financial Results CINCINNATI, April 26, 2012 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its first quarter ended March 31, 2012. Year-Over-Year Highlights: • Gross profit increase of 9.9% to $368.1 million; 115 basis-point expansion in gross margin • Long-Term Care Group ad
April 19, 2012	DEF 14A	- OMNICARE PROXY DEF 14A 1 omnicareproxy.htm OMNICARE PROXY UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary
March 29, 2012	EX-99.1	OMNICARE ANNOUNCES EXCHANGE TRANSACTIONS IN CONNECTION WITH ITS 3.75% CONVERTIBLE SENIOR SUBORDINATED NOTES EX-99.1 4 d326209dex991.htm PRESS RELEASE OF OMNICARE, INC. DATED MARCH 29, 2012 Exhibit 99.1 OMNICARE ANNOUNCES EXCHANGE TRANSACTIONS IN CONNECTION WITH ITS 3.75% CONVERTIBLE SENIOR SUBORDINATED NOTES COVINGTON, Ky., March 29, 2012 — Omnicare, Inc. (NYSE: OCR) — The Company has entered into separate, privately negotiated exchange agreements under which it will retire $ 256.946 million in aggregat
March 29, 2012	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of Earliest Event Reported) – March 29, 2012 OMNICARE, INC. (Exact Name of Registrant as Specified in Charter) DELAWARE 1-8269 31-1001351 (State or Other Jurisdiction of Incorporation) (Commission File Number
March 29, 2012	EX-4.2	OMNICARE, INC., Each of the Guarantors Named Herein U.S. BANK NATIONAL ASSOCIATION (as successor trustee to SunTrust Bank), EIGHTH SUPPLEMENTAL INDENTURE Dated as of April 3, 2012 Dated as of June 13, 2003 3.75% Convertible Senior Subordinated Notes EX-4.2 2 d326209dex42.htm FORM OF EIGHTH SUPPLEMENTAL INDENTURE Exhibit 4.2 OMNICARE, INC., Issuer Each of the Guarantors Named Herein and U.S. BANK NATIONAL ASSOCIATION (as successor trustee to SunTrust Bank), Trustee EIGHTH SUPPLEMENTAL INDENTURE Dated as of April 3, 2012 to INDENTURE Dated as of June 13, 2003 3.75% Convertible Senior Subordinated Notes Due 2042 TABLE OF CONTENTS Page ARTICLE I
March 29, 2012	EX-10.1	EXCHANGE AGREEMENT Exhibit 10.1 EXCHANGE AGREEMENT (the “Undersigned”), for itself and on behalf of the beneficial owners listed on Exhibit A hereto (“Accounts”) for whom the Undersigned holds contractual and investment authority (each Account, as well as the Undersigned if it is exchanging Existing Notes (as defined below) hereunder, a “Holder”), enters into this Exchange Agreement (the “Agreement”) with Omnicare,
March 6, 2012	8-K	Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 a8-kshell.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2012 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 1-826
March 6, 2012	EX-99.1	EX-99.1 EX-99.1 2 ex991slidepresentation.htm SLIDE PRESENTATION
March 1, 2012	EX-99.1	Omnicare Adopts Rule 10b5-1 Plan in Conjunction with Share Repurchase Program Exhibit 99.1 news release Omnicare Adopts Rule 10b5-1 Plan in Conjunction with Share Repurchase Program COVINGTON, Ky., March 1, 2012 - Omnicare, Inc. (NYSE:OCR), announced today that it has adopted a Rule 10b5-1 plan for the purpose of repurchasing up to $75 million of its common stock in accordance with guidelines specified under Rule 10b5-1 of the Securities Exchange Act of 1934 and the Company
March 1, 2012	8-K	Financial Statements and Exhibits, Other Events 8-K 1 a8-kshell3112.htm 8-K SHELL UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of Earliest Event Reported) - March 1, 2012 OMNICARE, INC. (Exact Name of Registrant as Specified in Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 1-8269 (
February 23, 2012	EX-99.2	EX-99.2 EX-99.2 3 ocrerex992.htm 2011 Q4 SUPPLIMENTAL SLIDES
February 23, 2012	EX-99.1	Omnicare Reports Fourth-Quarter and Full-Year 2011 Financial Results, Additional 2012 Guidance EX-99.1 2 ocrerex991.htm 2011 Q4 PRESS RELEASE Exhibit 99.1 news release Omnicare Reports Fourth-Quarter and Full-Year 2011 Financial Results, Additional 2012 Guidance COVINGTON, Ky., February 23, 2012 - Omnicare, Inc. (NYSE:OCR) reported today financial results for its fourth quarter and full year ended December 31, 2011. Fourth-Quarter Highlights: • Gross profit of $359.7 million; 69 basis point
February 23, 2012	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a8-k2x23x12.htm 2011 Q4 PRESS RELEASE 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2012 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction of Inco
February 21, 2012	EX-99.(A)(5)(S)	OMNICARE ANNOUNCES EXPIRATION OF ITS TENDER OFFER TO ACQUIRE PHARMERICA EX-99.(A)(5)(S) 2 a11-2555329ex99da5s.htm EX-99.(A)(5)(S) Exhibit (a)(5)(S) news release OMNICARE ANNOUNCES EXPIRATION OF ITS TENDER OFFER TO ACQUIRE PHARMERICA COVINGTON, Ky., February 21, 2012 — Omnicare, Inc. (NYSE:OCR) today announced that it has allowed its tender offer to acquire all of the outstanding shares of PharMerica Corporation (NYSE: PMC) common stock for $15.00 per share in cash to
February 21, 2012	SC TO-T/A	- AMENDMENT SC TO-T/A 1 a11-2555329sctota.htm AMENDMENT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO/A (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 17) PHARMERICA CORPORATION (Name of Subject Company (Issuer)) PHILADELPHIA ACQUISITION SUB, INC. OMNICARE, INC. (Names of Filing Persons (Offerors)) Common S
February 14, 2012	SC 13G	OCR / / HARRIS ASSOCIATES L P Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* OMNICARE (Name of Issuer) Common Stock (Title of Class of Securities) 681904108 (CUSIP Number) December 30, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is fil
February 6, 2012	SC 13G/A	OCR / / IRIDIAN ASSET MANAGEMENT LLC/CT Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* Omnicare, Inc.. (Name of Issuer) Common Stock (Title of Class of Securities) 681904108 (CUSIP Number) December 31, 2011 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedu
February 3, 2012	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of Earliest Event Reported) – January 30, 2012 OMNICARE, INC. (Exact Name of Registrant as Specified in Charter) DELAWARE (State or Other Jurisdiction of Incorporation) 1-8269 (Commission File Number) 31-1001
January 30, 2012	SC TO-T/A	- AMENDMENT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO/A (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 16) PHARMERICA CORPORATION (Name of Subject Company (Issuer)) PHILADELPHIA ACQUISITION SUB, INC. OMNICARE, INC. (Names of Filing Persons (Offerors)) Common Stock, Par Value $0.01 Per Share (Title of Cl
January 30, 2012	EX-99.(A)(5)(R)	OMNICARE COMMENTS ON FTC POSITION EX-99.(A)(5)(R) 2 a11-2555328ex99da5r.htm EX-99.(A)(5)(R) Exhibit (a)(5)(R) news release OMNICARE COMMENTS ON FTC POSITION COVINGTON, Ky., January 27, 2012 — Omnicare, Inc. (NYSE:OCR) today issued the following statement responding to the Federal Trade Commission’s (FTC) split (3 to 1) decision to issue an administrative complaint to block Omnicare’s offer to purchase all outstanding shares of Pha
January 27, 2012	SC TO-T/A	- AMENDMENT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO/A (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 15) PHARMERICA CORPORATION (Name of Subject Company (Issuer)) PHILADELPHIA ACQUISITION SUB, INC. OMNICARE, INC. (Names of Filing Persons (Offerors)) Common Stock, Par Value $0.01 Per Share (Title of Cl
January 27, 2012	EX-99.(A)(5)(Q)	OMNICARE EXTENDS TENDER OFFER FOR PHARMERICA UNTIL FEBRUARY 17, 2012 Exhibit (a)(5)(Q) news release OMNICARE EXTENDS TENDER OFFER FOR PHARMERICA UNTIL FEBRUARY 17, 2012 COVINGTON, Ky.
January 19, 2012	SC TO-T/A	- AMENDMENT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO/A (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 14) PHARMERICA CORPORATION (Name of Subject Company (Issuer)) PHILADELPHIA ACQUISITION SUB, INC. OMNICARE, INC. (Names of Filing Persons (Offerors)) Common Stock, Par Value $0.01 Per Share (Title of Cl
January 19, 2012	EX-99.(A)(5)(P)	OMNICARE EXTENDS TENDER OFFER FOR PHARMERICA UNTIL JANUARY 27, 2012 EX-99.(A)(5)(P) 2 a11-2555326ex99da5p.htm EX-99.(A)(5)(P) Exhibit (a)(5)(P) news release OMNICARE EXTENDS TENDER OFFER FOR PHARMERICA UNTIL JANUARY 27, 2012 COVINGTON, Ky., January 19, 2012 — Omnicare, Inc. (NYSE:OCR) today announced that it has extended its offer to purchase all outstanding shares of PharMerica Corporation (NYSE: PMC) common stock for $15.00 per share in cash to 5:00 p.m., New Yo
January 10, 2012	EX-99.1	1 Cash Flow Generation Specialty Care Group Omnicare’s Fundamental Objective Focused on Growth and Creating Value Value Creation Sizing Up the Business 4 Long-Term Care and Specialty Care represent two platforms for growth Industry Growth Dynamics Co EX-99.1 2 exhibit99-1.htm JP MORGAN EXHIBIT 99.1 SLIDES 1 Forward-Looking Statements Forward-looking Statements Certain of the statements made today and listed within the following presentation slides are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, all statements regarding t
January 10, 2012	8-K	Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 form8kjpmorgan.htm JP MORGAN CONFERENCE FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): January 10, 2012 Omnicare, Inc. (Exact name of Registrant as specified in its Charter) Delaware (State or Other Jurisdiction o
December 13, 2011	CORRESP	- CORRESP 1 filename1.htm [LETTERHEAD OF OMNICARE, INC.] VIA EDGAR December 13, 2011 Mr. Jim B. Rosenberg Senior Assistant Chief Accountant United States Securities and Exchange Commission Division of Corporate Finance Mail Stop 4720 Washington, D.C. 20549 Re: Omnicare, Inc. Form 10-K for Fiscal Year Ended December 31, 2010 Filed February 24, 2011 File NO. 001-08269 Dear Mr. Rosenberg: This letter c
November 10, 2011	CORRESP	- Dewey & LeBoeuf LLP 1301 Avenue of the Americas New York, NY 10019-6092 T +1 212 259-8000 F +1 212 259-6333 November 10, 2011 Daniel F.
September 23, 2011	CORRESP	- Dewey & LeBoeuf LLP 1301 Avenue of the Americas New York, NY 10019-6092 T +1 212 259-8000 F +1 212 259-6333 September 23, 2011 Daniel F.

OCR / - Документы SEC, Годовой отчет, Доверенное заявление

Основная статистика

SEC Filings

SEC Filings (Chronological Order)